Thrombospondin and vascular endothelial growth factor are cyclically expressed in an inverse pattern during bovine ovarian follicle development

Biology of Reproduction

Volumn 72, Issue 5, 2005, Pages 1071-1078

  Greenaway, James ^a   Gentry, Patricia A ^a   Feige, Jean Jacques ^b   LaMarre, Jonathan ^a   Petrik, Jim J ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b CEA GRENOBLE   (France)

Author keywords

Follicle; Follicular development; Granulosa cells; Growth factors; Ovary

Indexed keywords

FOLLITROPIN; MESSENGER RNA; THROMBOSPONDIN; THROMBOSPONDIN 1; THROMBOSPONDIN 2; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CELL SELECTION; CONTROLLED STUDY; COW; GRANULOSA CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; OVARY CELL; OVARY FOLLICLE DEVELOPMENT; OVARY FOLLICLE MATURATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SLAUGHTERHOUSE; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTIGENS, CD36; CATTLE; FEMALE; FOLLICULAR FLUID; GENE EXPRESSION REGULATION; GRANULOSA CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; OVARIAN FOLLICLE; OVARY; RNA, MESSENGER; THROMBOSPONDIN 1; THROMBOSPONDINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; BOVINAE;

EID: 17444377150     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.104.031120     Document Type: Article

References (60)

1. Tsafriri A. Ovulation as a tissue remodeling process. Adv Exp Med Biol 1995; 377:121-140.
2. Redmer DA, Grazul AT, Kirsch JD, Reynolds LP. Angiogenic activity of bovine corpora lutea at several stages of luteal development. J Reprod Fertil 1988; 82:627-634.
3. Plendl J. Angiogenesis and vascular regression in the ovary. Anat Histol Embryol 2000; 29:257-266.
4. Acosta TJ, Hayashi KG, Ohtani M, Miyamoto A. Local changes in blood flow within the preovulatory follicle wall and early corpus luteum in cows. Reproduction 2003; 125:759-767.
5. Yang MY, Rajmahendran R. Involvement of apoptosis in the atresia of nonovulatory dominant follicle during the bovine estrous cycle. Biol Reprod 2000; 63:1313-1321.
6. Hendriksen PJ, Gadella BM, Vos PL, Mullaart E, Kruip TA, Dieleman SJ. Follicular dynamics around the recruitment of the first follicular wave in the cow. Biol Reprod 2003; 69:2036-2044.
7. Richards JS, Russell DL, Ochsner S, Hsieh M, Doyle KH, Falender AE, Lo YK, Sharma SC. Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization. Recent Prog Horm Res 2002; 57:195-220.
8. Fraser HM, Lunn SF. Angiogenesis and its control in the female reproductive system. Br Med Bull 2000; 56:787-797.
9. Ferrara N, Frantz G, LeCouter J, Dillard-Telm L, Pham T, Draksharapu A, Giordano T, Peale F. Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries. Am J Pathol 2003; 162:1881-1893.
10. Richards JS, Jahnsen T, Hedin L, Lifka J, Ratoosh S, Durica JM, Goldring NB. Ovarian follicle development: from physiology to molecular biology. Rec Prog Horm Res 1987; 43:231-272.
11. Geisthovel F, Moretti-Rojas FJ, Asch RH. Insulin-like growth factors and thecal-granulosa cell function. Human Reprod 1990; 5:785-799.
12. Fournet N, Weitsman SR, Zachow RJ, Magottin DA. Transforming growth factor-β inhibits ovarian 17α-hydroxylase activity by a direct non-competitive mechanism. Endocrinology 1996; 137:166-174.
13. Maruo T, Ladines-Llave CA, Samoto T, Matsuo H, Manalo AS, Ito H, Mochizuki M. Expression of epidermal growth factor and its receptor in the human ovary during follicular growth and regression. Endocrinology 1993; 132:924-931.
14. Zimmermann RC, Hartman T, Kavic S, Pauli SA, Bohlen P, Sauer MV, Kitajewski J. Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle development. J Clin Invest 2003; 112:659-669.
15. Shimizu T, Jiang JY, Iijima K, Miyabayashi K, Ogawa Y, Sasada H, Sato E. Induction of follicular development by direct single injection of vascular endothelial growth factor gene fragments into the ovary. Biol Reprod 2003; 69:1388-1393.
16. Danforth DR, Arbogast LK, Ghosh S, Dickerman A, Rofagha R, Friedman CI. Vascular endothelial growth factor stimulates preantral follicle growth in the rat ovary. Biol Reprod 2003; 68:1736-1741.
17. Adams JC. Thrombospondins: multifunctional regulators of cell interactions. Annu Rev Cell Dev Biol 2001; 17:25-51.
18. Hornebeck W, Emonard H, Monboisse JC, Bellon G. Matrix-directed regulation of pericellular proteolysis and tumor progression. Semin Cancer Biol 2002; 12:231-241.
19. Hogg PJ, Hotchkiss KA. Role of thrombospondins in vascular biology. In: Berndt MC (ed.), Platelets, Thrombosis and the Vessel Wall. Toronto, ON, Canada: Harwood Academic Publishers; 2000: 253-266.
20. Gao AG, Lindberg FP, Finn MB, Blystone SD, Brown EJ, Frazier WA. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J Biol Chem 1996; 271:21-24.
21. Pfander D, Cramer T, Deuerling D, Weseloh G, Swoboda B. Expression of thrombospondin-1 and its receptor CD36 in human osteoarthritis cartilage. Ann Rheum Dis 2000; 59:448-454.
22. Carron JA, Wagstaff SC, Gallagher JA, Bowler WB. A CD36-binding peptide from the thrombospondin-1 can stimulate resorption by osteoclasts in vitro. Biochem Biophys Res Commun 2000; 270:1124-1127.
23. Dryefus M, Dardik R, Sun BS, Amsterdam A, Lahav J. Differentiation- controlled synthesis and binding of thrombospondin to granulosa cells. Endocrinology 1992; 130:2565-2570.
24. Higuchi T, Fujiwara H, Yamada S, Tatsumi K, Kataoka N, Itoh K, Maeda M, Fujita J, Fujii S. Co-expression of integrin-associated protein (IAP/CD47) and its ligand thrombospondin-1 on human granulosa and large luteal cells. Mol Hum Reprod 1999; 5:920-926.
25. Petrik JJ, Gentry PA, Feige J-J, LaMarre J. Expression and localization of thrombospondin-1 and -2 and their cell surface receptor, CD36 during rat follicular development and formation of the corpus luteum. Biol Reprod 2002; 67:1522-1531.
26. Bagavandoss P, Sage EH, Vernon RB. Secreted protein, acidic and rich in cysteine (SPARC) and thrombospondin in the developing follicle and corpus luteum of the rat. J Histochem Cytochem 1998; 46:1043-1049.
27. Ferrara N, Chen H, Davis-Smyth T, Gerber HP, Thuy-Nhung N, Peers D, Chisholm V, Hillan KJ, Schwall RH. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med 1998; 4:336-340.
28. Shimizu T, Jiang JY, Sasada H, Sato E. Changes of messenger RNA expression of angiogenic factors and related receptors during follicular development in gilts. Biol Reprod 2002; 67:1846-1852.
29. Barboni B, Turriani M, Giovanna G, Spiinaci M, Bacci ML, Forni M, Mattioli M. Vascular endothelial growth factor production in growing pig antral follicles. Biol Reprod 2000; 63:854-864.
30. Watson ED, Al-Zi'abi MO. Characterization of morphology and angiogenesis in follicles of mares during spring transition and the breeding season. Reproduction 2002; 124:227-234.
31. Van Blerkom J, Antczak M, Schrader R. The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics. Hum Reprod 1997; 12:1047-1055.
32. Kaio E, Tanaka S, Oka S, Hiyama T, Kitadai Y, Haruma K, Chayama K. Clinical significance of thrombospondin-1 expression in relation to vascular endothelial growth factor and interleukin-10 expression at the deepest invasive tumor site of advanced colorectal carcinoma. Int J Oncol 2003; 23:901-911.
33. Baltaci S, Orhan D, Gogus C, Filiz E, Tulunay O, Gogus O. Thrombospondin-1, vascular endothelial growth factor expression and microvessel density in renal cell carcinoma and their relationship with multifocality. Eur Urol 2003; 44:76-81.
34. Kwak C, Jin RJ, Lee C, Park MS, Lee SE. Thrombospondin-1, vascular endothelial growth factor expression, and their relationship with p53 status in prostate cancer and benign prostate hyperplasia. BJU Int 2002; 89:303-309.
35. Doll JA, Reiher FK, Crawford SE, Pins MR, Campbell SC, Bouck NP. Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate. Prostate 2001; 49:293-305.
36. Yang MY, Rajmahendran R. Morphological and biochemical identification of apoptosis in small, medium, and large bovine follicles and the effects of follicle-stimulating hormone and insulin-like growth factor-I on spontaneous apoptosis in cultured bovine granulosa cells. Biol Reprod 2000; 62:1209-1217.
37. Hsu SM, Raine L, Fanger H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29:577-580.
38. Armstrong LC, Bjorkblom B, Hankenson KD, Siadak AW, Stiles CE, Bornstein P. Thrombospondin 2 inhibits microvascular endothelial cell proliferation by a caspase-independent mechanism. Mol Biol Cell 2002; 13:1893-1905.
39. Hawighorst T, Oura H, Streit M, Janes L, Nguyen L, Brown LF, Oliver G, Jackson DG, Detmar M. Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice. Oncogene 2002; 21:7945-7956.
40. Fontanini G, Boldrini L, Calcinai A, Chine S, Lucchi M, Mussi A, Angeletti CA, Basolo F, Bevilacqua G. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density. Clin Cancer Res 1999; 5:155-161.
41. Shafiee A, Penn JS, Krutzsh HC, Inman JK, Roberts DD, Blake DA. Inhibition of retinal angiogenesis by peptides derived from thrombospondin-1. Invest Opthalmol Vis Sci 2000; 41:2378-2388.
42. Lawler J. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Mol Med 2002; 6:1-12.
43. Vailhe B, Feige JJ. Thrombospondins as anti-angiogenic therapeutic agents. Curr Pharm Des 2003; 9:583-588.
44. Bocci G, Francia G, Man S, Lawler J, Kerbel RS. Thrombospondin-1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy. Proc Natl Acad Sci U S A 2003; 100:12917-12922.
45. Zhang YW, Su Y, Volpert OV, Vande Woude GF. Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proc Natl Acad Sci U S A 2003; 100:12718-12723.
46. Rofstad EK, Henriksen K, Galappathi K, Mathiesen B. Antiangiogenic treatment with thrombospondin-1 enhances primary tumour radiation response and prevents growth of dormant pulmonary micrometastases after curative radiation therapy in human melanoma xenografts. Cancer Res 2003; 63:4055-4061.
47. Jin RJ, Kwak C, Lee SG, Lee CH, Soo CG, Park MS, Lee E, Lee SE. The application of an anti-angiogenic gene (thrombospondin-1) in the treatment of human prostate cancer xenografts. Cancer Gene Ther 2000; 7:1537-1542.
48. Miyanaga K, Kato Y, Nakamura T, Matsumura M, Amaya H, Horiuchi T, Chiba Y, Tanaka K. Expression and role of thrombospondin-1 in colorectal cancer. Anticancer Res 2003; 22:3941-3948.
49. Lawler JW, Slayter HS, Coligan JE. Isolation and characterization of a high molecular weight glycoprotein from human blood platelets. J Biol Chem 1978; 253:8609-8616.
50. Hawighorst T, Velasco P, Striet M, Hong YK, Kyriakides TR, Browth LF, Bornstein P, Detmar M. Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism. EMBO J 2001; 20:2631-2640.
51. Kamat BR, Brown LF, Manseau EJ, Senger DR, Dvorak HF. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am J Pathol 1995; 146:157-165.
52. Greenaway J, Connor K, Pedersen HG, Coomber BL, LaMarre J, Petrik J. VEGF and its receptor, Flk-1/KDR are cytoprotective in the extravascular compartment of the ovarian follicle. Endocrinology 2004; 145:2896-2905.
53. Behzadian MA, Windsor LJ, Ghaly N, Liou G, Tsai NT, Caldwell RB. VEGF-induced paracellular permeability in cultured endothelial cells involves urokinase and its receptor. FASEB J 2003; 17:752-754.
54. Gomez R, Simon C, Remohi J, Pellicer J. Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability. Biol Reprod 2003; 68:2164-2171.
55. Wang TH, Horng SG, Chang CL, Wu HM, Tsai YJ, Wang HS, Soong YK. Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor. J Clin Endocrinol Metab 2002; 87:3300-3308.
56. Nilsson EE, Doraiswamy V, Skinner MK. Transforming growth factor-beta isoform expression during bovine ovarian antral follicle development. Mol Reprod Dev 2003; 66:237-246.
57. Teerds KJ, Dorrington JH. Immunohistochemical localization of transforming growth factor-beta 1 and -beta 2 during follicular development in the rat ovary. Mol Cell Endocrinol 1992; 84:R7-R13.
58. Negoescu A, Lafeuillade B, Pellerin S, Chambaz EM, Feige JJ. Transforming growth factor beta stimulates both thrombospondin-1 and CISP/Thrombospondin-2 synthesis by bovine adrenocortical cells. Exp Cell Res 1995; 217:404-409.
59. Ojeda SR, Advis JP, Andrews WW. Neuroendocrine control of the onset of puberty in the rat. Fed Proc 1980; 39:2365-2371.
60. Richards JS, Uilenbroek JT, Jonassen JA. Follicular growth in the rat: a reevaluation of the roles of FSH and LH. Adv Exp Med Biol 1979; 112:11-26.